IDH1 and glioblastoma: Data could be categorized according to miRNA expression (mi1 to mi5), DNA methylation profiles (dm1 to dm6), IDH status (mutant, wild-type), Gender (female, male), multi-omics (IDH mutant and nmf1 to nmf3), MGMT promoter methylation status (methylated, not methylated), age (less or above 55y), immune profile (im1 to im4), pathologic subtype (classical, IDH mutant, mesenchymal, proneural), WHO grade (high, low) and GTMEI-score: the quantification of immune infiltration patterns in any individual GBM sample [20].